NCT02881892View on ClinicalTrials.gov

Iplasma IL6, Procalcitonin and VEGF and Dialysate Level in CAPD Patients

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

June 30, 2014

Conditions
Chronic Kidney Disease
Interventions
OTHER

Measure plasma and dialysate level of IL-6, procalcitonin and VEGF

correlation between plasma levels, dialysate appearance rate of VEGF, inflammatory cytokines (IL- 6, procalcitonin) and PSTR, dialysis adequacy in CAPD patients.

Trial Locations (1)

10300

Renal Unit, BMA Medical College and Vajira Hospital, Bangkok

All Listed Sponsors
lead

Bangkok Metropolitan Administration Medical College and Vajira Hospital

OTHER_GOV

NCT02881892 - Iplasma IL6, Procalcitonin and VEGF and Dialysate Level in CAPD Patients | Biotech Hunter | Biotech Hunter